Universal Beteiligungs und Servicegesellschaft mbH Raises Stock Position in Corteva, Inc. $CTVA

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH raised its Corteva stake by 8.7% in Q4 to 586,914 shares (about 0.09% of the company), valued at roughly $39.36 million.
• Several large institutions (including Perpetual, Pacer, Amundi, Squarepoint and Man Group) materially boosted positions in Corteva, and hedge funds/institutional investors now own about 81.54% of the stock.
• Corteva reported Q results with $0.22 EPS (in line) but revenue of $3.91B missed expectations, set FY2026 EPS guidance of $3.45–3.70 (consensus ~3.62), pays a $0.18 quarterly dividend (~0.9% yield), and has a consensus analyst target of $84.90.

Universal Beteiligungs und Servicegesellschaft mbH boosted its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 8.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 586,914 shares of the company's stock after purchasing an additional 47,015 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.09% of Corteva worth $39,355,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of CTVA. Perpetual Ltd raised its stake in Corteva by 78,688.5% during the fourth quarter. Perpetual Ltd now owns 2,615,779 shares of the company's stock worth $175,336,000 after purchasing an additional 2,612,459 shares during the period. Pacer Advisors Inc. raised its stake in Corteva by 4,007.1% during the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company's stock worth $165,164,000 after purchasing an additional 2,382,715 shares during the period. Amundi raised its stake in Corteva by 125.3% during the third quarter. Amundi now owns 3,415,554 shares of the company's stock worth $219,620,000 after purchasing an additional 1,899,248 shares during the period. Squarepoint Ops LLC raised its stake in Corteva by 423.6% during the third quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company's stock worth $117,550,000 after purchasing an additional 1,406,199 shares during the period. Finally, Man Group plc raised its stake in shares of Corteva by 16,474.3% in the 3rd quarter. Man Group plc now owns 1,294,125 shares of the company's stock valued at $87,522,000 after acquiring an additional 1,286,317 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Brian Titus sold 8,311 shares of the company's stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.15% of the company's stock.

Corteva Trading Up 0.4%

NYSE CTVA opened at $79.66 on Friday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The stock has a market capitalization of $53.48 billion, a PE ratio of 50.41, a price-to-earnings-growth ratio of 2.72 and a beta of 0.68. The firm has a 50 day moving average of $80.00 and a two-hundred day moving average of $71.49.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company had revenue of $3.91 billion during the quarter, compared to analysts' expectations of $4.23 billion. During the same quarter in the previous year, the business posted $0.32 EPS. The firm's revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts expect that Corteva, Inc. will post 3.62 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were issued a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva's dividend payout ratio is presently 45.57%.

Wall Street Analysts Forecast Growth

CTVA has been the topic of a number of research analyst reports. UBS Group boosted their price target on shares of Corteva from $80.00 to $88.00 and gave the company a "neutral" rating in a research note on Thursday, April 9th. Jefferies Financial Group upped their target price on shares of Corteva from $85.00 to $95.00 and gave the stock a "buy" rating in a research note on Monday, March 2nd. Royal Bank Of Canada upped their target price on shares of Corteva from $80.00 to $89.00 and gave the stock an "outperform" rating in a research note on Thursday, February 5th. The Goldman Sachs Group upped their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a "buy" rating in a research note on Tuesday, April 14th. Finally, Zacks Research downgraded shares of Corteva from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 20th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $84.90.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.